1 Result: Hitachi Chemical
Caladrius Biosciences Subsidiary PCT, LLC Enters Into Global Collaboration and License Agreement with Hitachi Chemical
March 14th, 2016
Caladrius Sells 19.9% equity stake in PCT for $19.4 million Licenses cell therapy technology for certain Asian territories for $5.6 million and future royalties BASKING RIDGE, N.J. / CRWEPRESSRELEASE / March 14, 2016 — Caladrius Bios. Read more
Want To Find Some News?
News By Industries
August 30th, 2016August 29th, 2016August 29th, 2016